Location: Home
  • search
  • go
  • Relate News
  • 8/12/2021Junshi and Coherus Announce U.S. FDA Breakthrough Therapy Designation...
  • 8/11/2021China Approves Clinical Trial Mixing Covid-19 Vaccines from Sinovac an...
  • 8/11/2021Sinopharm Drops Plan to Take China TCM Holdings Private
  • 8/11/2021Bloomberg: China Signals Businesses Face Greater Regulation in Coming ...
  • 8/10/2021China's Healthcare Appears Ripe For Digitization
  • 8/10/2021Merck, Novo, Sanofi and More Pull Off China Growth Thanks to Price Man...
  • 8/10/2021Seagen and RemeGen Announce Exclusive Worldwide License and Co-Develop...
  • 8/10/2021HUTCHMED and Epizyme Announce Strategic Collaboration for TAZVERIK (ta...
  • 8/10/2021Chinese Vitamin C Price-fixing Lawsuit Tossed by U.S. Appeals Court
  • 8/10/2021PhaseBio and SFJ Pharma Announce Chinese IND Approval for Bentracimab
  • 8/8/2021Akeso/Sino Biopharma's PD-1 Penpulimab Granted Marketing Approval in C...
  • 8/6/2021Inmagene and Kissei Enter into an Exclusive License Agreement for Fost...
  • 8/6/2021Oyster Point Announces License Deal with Ji Xing Pharma for Novel Dry...
  • 8/6/2021Recent Executive Moves
  • 8/6/2021NHC Releases 2020 Annual Health Sector Development Report (Full Summa...
  • 8/5/2021Hanmi Pharma and Lego Chem Bio Enter Partnership Deal to Co-develop AD...
  • 8/5/2021Promega and Henlius Developing MSI Companion Diagnostic IVD Kit for Se...
  • 8/5/2021Review of China Healthcare Sector Performance in H1/2021
  • 8/5/2021Forbes: Bayer Sees A Golden Age For China's Pharmaceutical Market
  • 8/5/2021China Is Poised To Enter The Global Injectable Market – An Expert CDM...
  • 8/4/2021NMPA Reportedly Seeking Comments on Proposed Regulation of Online Drug...
  • 8/3/2021Burning Rock and IMPACT Therapeutics Announce a Global Partnership for...
  • 8/3/2021WuXi STA Completes Acquisition of BMS Manufacturing Facility in Couvet...
  • 8/2/2021SMEI: Chinese Retail Pharmacy Market (Offline and Online) Rose 12.5% i...
  • 8/2/2021SMEI Predicts Restructure of Chinese Drug Retail Market and Further Bo...
  • 8/2/2021Eisai's Anti-Epileptic Fycompa Approved in China as Monotherapy for Pa...
  • 8/2/2021WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Cert...
  • 8/2/2021Chinese Biosimilars Surge between 2018 and 2020 Due to New NMPA Regula...
  • 8/2/2021Biopharma Companies Still Waiting for Clarity on China's New Patent Te...
  • 8/1/2021NHSA Publicizes the List of Drugs Passing Form Evaluation for Inclusio...
  • Page:88/360 Total number of articles:10791: [First][<<] [86] [87] [88] [89] [90] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group